Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported annual fiscal-period values; no daily interpolation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
-14.63x
EV/EBIT RATIO AVG 3Y
-10.28x
EV/EBIT RATIO AVG 5Y
-10.52x
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Scholar Rock Holding Corporation
Market Cap
$6.81B
EV/EBIT Ratio
N/A
TTM Avg
-14.63x
3Y Avg
-10.28x
5Y Avg
-10.52x
Market Cap
$6.78B
EV/EBIT Ratio
20.77x
TTM Avg
18.46x
3Y Avg
22.33x
5Y Avg
22.20x
Market Cap
$6.60B
EV/EBIT Ratio
259.98x
TTM Avg
122.21x
3Y Avg
156.68x
5Y Avg
156.68x
Market Cap
$7.77B
EV/EBIT Ratio
10.17x
TTM Avg
342.11x
3Y Avg
141.99x
5Y Avg
141.99x
Market Cap
$5.41B
EV/EBIT Ratio
28.86x
TTM Avg
27.93x
3Y Avg
35.22x
5Y Avg
45.72x
Market Cap
$10.04B
EV/EBIT Ratio
26.18x
TTM Avg
30.52x
3Y Avg
30.16x
5Y Avg
26.88x
Market Cap
$10.23B
EV/EBIT Ratio
18.00x
TTM Avg
16.30x
3Y Avg
16.60x
5Y Avg
15.58x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Scholar Rock Holding Corporation (SRRK) | $6.81B | N/A | -14.63x | -10.28x | -10.52x |
| Chemed Corporation (CHE)vs › | $6.78B | 20.77x | 18.46x | 22.33x | 22.20x |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.60B | 259.98x | 122.21x | 156.68x | 156.68x |
| Oscar Health, Inc. (OSCR)vs › | $7.77B | 10.17x | 342.11x | 141.99x | 141.99x |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.41B | 28.86x | 27.93x | 35.22x | 45.72x |
| Doximity, Inc. (DOCS)vs › | $5.00B | 24.95x | 31.10x | 39.57x | 58.61x |
| The Ensign Group, Inc. (ENSG)vs › | $10.04B | 26.18x | 30.52x | 30.16x | 26.88x |
| Henry Schein, Inc. (HSIC)vs › | $10.23B | 18.00x | 16.30x | 16.60x | 15.58x |
| Insulet Corp. (PODD)vs › | $10.30B | 20.80x | 37.98x | 63.64x | 173.51x |
| Universal Health Services, Inc. (UHS)vs › | $10.31B | 7.45x | 8.82x | 11.29x | 11.64x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2025-12-31 | -12.58x |
| 2024-12-31 | -16.67x |
| 2023-12-31 | -8.11x |
| 2022-12-31 | -3.76x |
| 2021-12-31 | -6.03x |
| 2020-12-31 | -15.98x |
| 2019-12-31 | -6.09x |
| 2018-12-31 | -4.83x |
| 2017-12-31 | -8.87x |
| 2016-12-31 | -16.61x |
